Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT03666351
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 128 participants
- Registry
-
NCT03666351
-
- Other papers using this trial's data
- Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03666351. Randomized; single masking; primary purpose treatment. Start 2018-10-18 (actual); primary completion 2022-07-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
- Condition
- Aortic Stenosis
- Condition
- Aortic Regurgitation
- Condition
- Hypertension
- Condition
- LVM
- Condition
- Left Ventricular Hypertrophy
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Drug)
- Losartan
- Intervention (Drug)
- Losartan and Amlodipine
- Intervention (Drug)
- Amlodipine/Losartan/Chlorthalidone
- Intervention (Drug)
- current treatment
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct03666351- Content hash
fe3294a9e28f529d0762876c3b7314676e1c6896d6438236bc98aee7555e4d88